Cortney Birschbach, OD
Optometrist · Fond du Lac, WINPI 1376105700
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,027 of the $4,572 with a category attached, or 66.2%. 16 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 59.7% of the total. Reporting peaked in 2022 at $2,230 and has fallen 86.0% since, to $312 in 2025. Among optometrist clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $35.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$3K
- Bausch & Lomb Americas Inc.$354
- Bausch & Lomb, A Division Of Bausch Health US, LLC$250
- Coopervision Inc.$227
- Sun Pharmaceutical Industries Inc.$185
- Alcon$150
- plus $675 from 10 others
What the payments were for
- Consulting fees$1,54534%
- Food & beverage$3,02766%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 35 | $2,731 |
| Bausch & Lomb Americas Inc. | 20 | $354 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 16 | $250 |
| Coopervision Inc. | 15 | $227 |
| Sun Pharmaceutical Industries Inc. | 4 | $185 |
| Alcon | 9 | $150 |
| AbbVie(2 entities) | 8 | $149 |
| Amgen | 1 | $120 |
| Novartis | 6 | $119 |
| Oyster Point Pharma, Inc. | 5 | $93 |
| Kala Pharmaceuticals, Inc. | 5 | $78 |
| Tarsus Pharmaceuticals, Inc. | 2 | $42 |
| Thea Pharma Inc. | 1 | $27 |
| Dompe US, Inc. | 1 | $25 |
| Plexus Optix, Inc. | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,572 in reported general payments places this provider in the 90th percentile of 867 optometrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 54 | $663 |
| Timolol Maleate | 22 | $342 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $148 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Fond du Lac
- Jessica KulickFond du Lac$8K
- Grant LepleyFond du Lac$7K
- David NelsonMadison$256K
- Jennifer FrieheMukwonago$234K
- Tessa SokolMadison$105K
- Christopher LopezClintonville$48K
- Jeff BanasMount Pleasant$46K
- Jessica SchiffbauerKenosha$27K
- Jeffrey ClementsSun Prairie$16K
- Douglas HinsonSturtevant$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.